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The ins and outs of receptor tyrosine phosphatases
Receptor tyrosine phosphatases interact with cell adhesion molecules to
transduce intracellular signals and alter cell-cell adhesion. Interactions with
protein complexes can localize these phosphatases to particular substrates.
Many cellular processes - including proliferation, differ-
entiation, motility and the outgrowth of processes - are
regulated by tyrosine phosphorylation of critical sub-
strates. The catalytically opposed activities of protein-
tyrosine kinases and protein-tyrosine phosphatases main-
tain an essential balance of phosphorylation levels. In
general, tyrosine phosphatases have higher constitutive
activity than tyrosine kinases, suggesting that they may
maintain a low level of tyrosine phosphorylation that is
punctuated by bursts of tyrosine kinase activity.
We shall focus on the interactions between receptor-
linked protein-tyrosine phosphatases and both extracellu-
lar ligands and intracellular substrates. Receptor tyrosine
phosphatases each have a large extracellular region, simi-
lar to those of cell adhesion molecules (CAMs), linked
via a transmembrane spanning segment to cytoplasmic
tyrosine phosphatase domains. Recent studies show that
the extracellular domain of the receptor tyrosine phos-
phatase RPTP3 (also known as PTPS) interacts with
three neural cell adhesion molecules [1-3]. The cytoplas-
mic domains of two other receptor tyrosine phosphatases,
PTPp. and DPTP1OD, interact with transmembrane pro-
teins that are substrates for their enzymatic activities
[4,5]. The repercussions of the binding of ligand to the
extracellular domain of a receptor tyrosine phosphatase
have not yet been defined; binding to ligands could mod-
ulate phosphatase activity and/or relocalize receptor tyro-
sine phosphatases within cells to bring them into contact
with potential substrates.
Interactions between ligands and the extracellular domains
of receptor tyrosine phosphatases
Studies of cell aggregation using transfected cell lines have
revealed that PTPIz and PTPK are homophilic adhesion
molecules [6]. The extracellular domains of these receptor
tyrosine phosphatases have identical organizations, con-
sisting of a MAM (meprin/a5/jL) domain, an immuno-
globulin-like domain, and four fibronectin type III (FN3)
repeats. When transfected cells expressing PTPt are
mixed with cells expressing PTPK, the two types of cells
coalesce into discrete homogenous aggregates. Despite
their structural similarity, therefore, the homophilic bind-
ing properties of PTP.t and PTPK are highly specific [7].
Some receptor tyrosine phosphatases can mediate
heterophilic adhesion: for example, the extracellular
domain of RPTPI interacts with several neural cell
adhesion molecules (Fig. 1). The extracellular region of
RPTPP3 is composed of an amino-terminal carbonic
anhydrase (CAH)-like domain, a single FN3 repeat, and
a large 'spacer' domain [8,9]. RPTP is a chondroitin
sulfate proteoglycan expressed in three forms, one
secreted and two membrane-bound [9,10]. The soluble
form of the extracellular domain, known as phosphacan,
is produced by translation of an alternatively spliced
RPTP3 mRNA [10]. Phosphacan binds at least three
ligands: the widely expressed neural adhesion molecules
N-CAM and Ng-CAM (L1, NILE) and the extracellular
matrix molecule tenascin [1,2]. The interactions of
phosphacan with these proteins may be mediated by the
spacer domain, as isolated CAH and FN3 domains do
not confer binding (Fig. la) [3]. Removal of the chon-
droitin sulfate moieties of phosphacan demonstrates that
the core protein is both necessary and sufficient for
phosphacan-CAM binding [1].
A more recent study [3], using both expression cloning
and affinity purification techniques, has demonstrated that
contactin (F3/F11) is a neuronal ligand for the RPTPP
CAH domain (Fig. la). Like the phosphacan/RPTPI3
ligands N-CAM and Ng-CAM, contactin is a member of
the immunoglobulin superfamily [11]. Contactin-express-
ing chick tectal neurons adhere to, and extend neurites
on, substrates made up of RPTP3 CAH domains. CAH
domain substrates also induce the differentiation of a
human neuroblastoma cell line. Significantly, contactin-
specific antibodies inhibit differentiation of these cells and
cause neurite retraction [3]. These results show that
engagement of contactin by the RPTPI3 CAH domain
activates a signal transduction pathway that instructs spe-
cific cells to adopt a neuronal fate and extend processes.
RPTPP is widely expressed on glial cells in the central
and peripheral nervous systems [12]. Interactions in vivo
between RPTPP and contactin must be restricted to
localized regions of the brain, however, because contactin
is expressed only on specific axon pathways during devel-
opment [13,14]. It is not clear whether the enzymatic
activity or intracellular localization of RPTPI is altered
by engagement of contactin. In contrast to the RPTPP-
mediated activation of contactin signaling, phosphacan
inhibits both N-CAM- and Ng-CAM-mediated adhe-
sion of glia and neurons; moreover, phosphacan forms a
nonpermissive substrate for neurite extension [1]. These
data suggest that binding to the extracellular domain of
RPTPI can block adhesion mediated by N-CAM and
Ng-CAM. Phosphacan could also inhibit the interactions
of contactin-expressing neurons with RPTP3-expressing
glial cells. As RNA and protein analyses suggest that
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phosphacan is the predominant form of RPTP3 [10,15],
these inhibitory interactions are likely to occur in vivo.
The outcomes of interactions between phosphacan/
RPTP3 and contactin are difficult to predict, because
contactin is part of a large multiprotein complex and may
transduce signals by way of interactions with Ng-CAM
within the same complex [11]. It is also noteworthy that
contactin is expressed both as a membrane-bound mol-
ecule anchored by a glycosylphosphatidylinositol (GPI)
linkage and as a soluble protein, which is cleaved from the
membrane [11]. Thus, it is unclear how a neuron express-
ing contactin, Ng-CAM and N-CAM would respond in
vivo to contact with glial cells that express RPTP3 and/or
secrete phosphacan. The interactions among neural cell
adhesion molecules and RPTP3 isoforms are likely to be
important, given the essential roles of neuron-glial
communication during brain development.
Interactions with the cytoplasmic domains of receptor
tyrosine phosphatases
Little is known about the signaling pathways downstream
of receptor tyrosine phosphatases, but recent work has
begun to identify proteins that interact with their
cytoplasmic domains. These could be tyrosine phospha-
tase substrates whose activities are modulated by tyrosine
phosphorylation; alternatively, associated proteins could
act as localization signals for the tyrosine phosphatases. A
recently identified cytoskeletal protein that interacts with
the carboxyl terminus of the receptor tyrosine phos-
phatase LAR may be critical for LAR localization within
cells [16]. Many tyrosine phosphatases do not exhibit
high substrate specificity in vitro, so specificity in vivo may
be determined in part by cellular compartmentalization.
PTPu, which is a homophilic adhesion molecule,
associates with a protein complex containing cadherins
and oa- and -catenins in both cultured cell and tissue
lysates [4]. Cadherins are homophilic Ca2 +-dependent
adhesion molecules that associate with catenins; catenins,
in turn, bind to the underlying actin cytoskeleton [17].
The cytoplasmic region of PTPu binds directly to E-cad-
herin in vitro (Fig. lb). Moreover, PTPp[, cadherins and
catenins are colocalized at points of cell-cell contact,
including adherens junctions. Treatment of cells with per-
vanadate, which is a global tyrosine phosphatase inhibitor,
Fig. 1. The interactions of receptor tyrosine phosphatases with CAMs and intracellular cytoskeletal complexes. (a) RPTP[3 binds to
multiple ligands: it associates with contactin via its CAH domain; the spacer domain interacts with both N-CAM and Ng-CAM; and its
FN3 domain also binds to an uncharacterized ligand expressed on glial cells. (b) PTPI. associates with components of adherens
junctions. It binds directly to cadherin, which is linked to the underlying cytoskeleton via the catenins. (c) DPTP1OD binds to the
cytoplasmic domain of gpl 50 and dephosphorylates tyrosine residues.
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produces a large increase in tyrosine phosphorylation of
cadherins [4]. Taken together, the data suggest that the
cadherins are endogenous substrates for PTP[p.
Cadherin-associated tyrosine phosphatases may be critical
players in cell-cell interactions, as phosphotyrosine
modification of the cadherin-catenin complex can alter
its adhesive properties; increased tyrosine phosphoryla-
tion of cadherins weakens intercellular adhesion via
adherens junctions [4]. Dephosphorylation of cadherins
by PTPp- may be a constitutive process that is essential
for maintaining junctional stability. On the intracellular
face of the junction, interactions among cytoplasmic
domains would ensure that PTPp. colocalizes with its
substrate, cadherin. Externally, homophilic adhesion
mediated by PTPI. could supplement homophilic cad-
herin adhesion. The avidity of intercellular adhesion
could be modulated as required by signal-driven increases
in tyrosine kinase activity that would transiently exceed
the rate of cadherin dephosphorylation by receptor tyro-
sine phosphatases.
Studies in our laboratory have focused on identification
of substrates for a set of Drosophila axonal receptor tyro-
sine phosphatases [18]. The cytoplasmic domain of one
of these, DPTP1OD, binds in vitro to a 150 kD glycopro-
tein, gpl50, a transmembrane protein whose extracellular
domain contains 18 leucine-rich repeat motifs homolo-
gous to those found in several Drosophila adhesion and
signaling proteins (Fig. c). These homologous proteins
include chaoptin, which is involved in photoreceptor
clustering, and connectin, an adhesion molecule ex-
pressed on a specific subset of motor neurons and their
muscle targets [19-21]. The short cytoplasmic domain of
gpl50 contains four tyrosine residues in sequence config-
urations that suggest they could bind to downstream sig-
naling molecules containing Src homology 2 (SH2)
domains. Phosphorylated gpl50 is a substrate in vitro for
DPTP1OD [5]. Our recent results indicate that gp150 can
be phosphorylated on tyrosine residues in vivo. Coexpres-
sion of DPTP1OD reverses this phosphorylation in a
dose-dependent manner (our unpublished observations),
suggesting that gp150 is a substrate for DPTP1OD in vivo.
This interaction may modulate the activity of a
downstream signal transduction pathway.
In summary, both the extracellular and cytoplasmic
domains of receptor tyrosine phosphatases can interact
with cell adhesion molecules, and these interactions have
functional consequences for both adhesion and signal
transduction.
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